Literature DB >> 1517799

Histologic factors in the grading and prognosis of astrocytoma grade I-IV.

E H Rutten1, W H Doesburg, J L Slooff.   

Abstract

The prognostic value of histologic or cytologic features were examined in 317 patients with an astrocytic glioma. Of 46 features examined 7 morphologic characteristics of nucleus and 5 of mesenchyma correlated well with grading according to Kernohan. The morphological characteristics of nucleus are cellularity, atypical nuclei, polymorphism, multinucleated cells, hyperchromasia, gigantic nuclei and mitosis. For mesenchyma these were vascularity, vascular endothelial proliferation, vascular glomeruli, necrosis with palisade formation and necrosis without palisade formation. Scoring of these items on a scale from 0 to 4 enables us to establish a nucleus-score (max. 28) and a mesenchyma-score (max. 20). Nucleus-score + mesenchyma-score less than or equal to 10 corresponds with astrocytoma grade II, less than or equal to 20 with grade III and greater than 20 with grade IV. A low nucleus-score in grade II (less than 5) predicts a long survival (greater than 10 years), a high nucleus-score a low survival (median 0.6 year). In grade III a low mesenchyma-score predicts a median survival of 1.25 years, a high mesenchyma-score a median survival of 0.38 year. This retrospective study shows that nucleus-score and mesenchyma-score correlate to grading according to Kernohan and are highly correlative to survival.

Entities:  

Mesh:

Year:  1992        PMID: 1517799     DOI: 10.1007/bf00172474

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  11 in total

1.  Prognostic factors in well-differentiated cerebral astrocytomas in the adult.

Authors:  R Soffietti; A Chiò; M T Giordana; E Vasario; D Schiffer
Journal:  Neurosurgery       Date:  1989-05       Impact factor: 4.654

2.  Prognostic value of histologic factors in adult cerebral astrocytoma.

Authors:  D Schiffer; A Chiò; M T Giordana; M Leone; R Soffietti
Journal:  Cancer       Date:  1988-04-01       Impact factor: 6.860

3.  Histologic and non-histologic factors correlated with survival time in supratentorial astrocytic tumors.

Authors:  F Cohadon; N Aouad; A Rougier; C Vital; J Rivel; J F Dartigues
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

4.  Patient age, histologic features, and length of survival in patients with glioblastoma multiforme.

Authors:  P C Burger; S B Green
Journal:  Cancer       Date:  1987-05-01       Impact factor: 6.860

5.  Automated image analysis, histologic malignancy grading, and survival in patients with astrocytic gliomas. Prognostic significance of nuclear count and nuclear area fraction.

Authors:  L H Klinken; N H Diemer; F Gjerris
Journal:  Clin Neuropathol       Date:  1984 May-Jun       Impact factor: 1.368

6.  Correlations between cytologic composition and biologic behavior in the glioblastoma multiforme. A postmortem study of 50 cases.

Authors:  F Giangaspero; P C Burger
Journal:  Cancer       Date:  1983-12-15       Impact factor: 6.860

7.  Mononuclear infiltrates in human intracranial tumors as a prognostic factor. Influence of preoperative steroid treatment. I. Glioblastoma.

Authors:  D K Böker; R Kalff; F Gullotta; S Weekes-Seifert; U Möhrer
Journal:  Clin Neuropathol       Date:  1984 Jul-Aug       Impact factor: 1.368

8.  Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas.

Authors:  J S Nelson; Y Tsukada; D Schoenfeld; K Fulling; J Lamarche; N Peress
Journal:  Cancer       Date:  1983-08-01       Impact factor: 6.860

9.  Anaplastic astrocytoma of the adult cerebrum. Prognostic value of histologic features.

Authors:  K H Fulling; D M Garcia
Journal:  Cancer       Date:  1985-03-01       Impact factor: 6.860

10.  Comparison of cytologic composition with microfluorometric DNA analysis of the glioblastoma multiforme and anaplastic astrocytoma.

Authors:  F Giangaspero; P Chieco; G Lisignoli; P C Burger
Journal:  Cancer       Date:  1987-07-01       Impact factor: 6.860

View more
  5 in total

1.  Vascularization pattern of C6 glioma is modified with medroxyprogesterone acetate and ibuprofen in Wistar rat brain.

Authors:  M A Altinoz; E Ozar; M Taskin; E Bozcali; A Bilir; T Altug; A Aydiner; A Sav
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

2.  The striate sign: peritumoural perfusion pattern of infiltrative primary and recurrent gliomas.

Authors:  Stella Blasel; Kea Franz; Michel Mittelbronn; Gerald Morawe; Alina Jurcoane; Stefanie Pellikan; Friedhelm Zanella; Elke Hattingen
Journal:  Neurosurg Rev       Date:  2010-03-02       Impact factor: 3.042

3.  High- and low-grade glioma differentiation: the role of percentage signal recovery evaluation in MR dynamic susceptibility contrast imaging.

Authors:  Italo Aprile; Giorgia Giovannelli; Paola Fiaschini; Marco Muti; Anna Kouleridou; Nevia Caputo
Journal:  Radiol Med       Date:  2015-03-12       Impact factor: 3.469

Review 4.  Imaging in neuro-oncology.

Authors:  Hari Nandu; Patrick Y Wen; Raymond Y Huang
Journal:  Ther Adv Neurol Disord       Date:  2018-02-28       Impact factor: 6.570

5.  A microRNA Link to Glioblastoma Heterogeneity.

Authors:  Sanjay K Singh; Alenoush Vartanian; Kelly Burrell; Gelareh Zadeh
Journal:  Cancers (Basel)       Date:  2012-09-03       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.